机译:日本血液透析患者二线治疗镧碳酸盐镧的临床疗效及成本效果
Division of Nephrology and Kidney Center Kobe University Graduate School of Medicine Kobe Japan;
Division of Nephrology and Kidney Center Kobe University Graduate School of Medicine Kobe Japan;
Department of Health Informatics Niigata University of Health and Welfare Niigata Japan;
Department of Blood Purification and Kidney Center Konan Hospital Kobe Japan;
Sumiyoshigawa Hospital Kobe Japan;
Sumiyoshigawa Clinic Kobe Japan;
Department of Internal Medicine Chibune General Hospital Osaka Japan;
Department of Nephrology Hara Genitourinary Hospital Kobe Japan;
Motomachi HD Clinic Kobe Japan;
Department of Nephrology and Blood Purification Center Rokko Island Hospital Kobe Japan;
Department of Medicine and Clinical Science Graduate School of Medical Science Kyushu University;
Division of Nephrology and Kidney Center Kobe University Graduate School of Medicine Kobe Japan;
Division of Nephrology and Kidney Center Kobe University Graduate School of Medicine Kobe Japan;
Division of Medical Statistics Kobe University Graduate School of Medicine Kobe Japan;
Division of Nephrology and Kidney Center Kobe University Graduate School of Medicine Kobe Japan;
机译:日本血液透析患者二线治疗镧碳酸盐镧的临床疗效及成本效果
机译:碳酸镧对正在接受血液透析的日本慢性肾脏病患者的高磷酸盐血症的一年疗效和安全性。
机译:日本血液透析患者的长期观测研究,完成了3年碳酸镧临床研究的临床研究
机译:组合化疗与多西紫杉醇和伊替康的疗效,作为晚期胃癌的第一或二线治疗
机译:优化患者肾病中的患者结果:血液透析中血管内管理临床实践指南的关键评价
机译:压碎的碳酸镧对接受管饲的血液透析患者的高磷酸盐血症的疗效
机译:碳酸镧作为二线疗法在日本血液透析患者中的临床疗效和成本效益